Changes in survival in de novo metastatic cancer in an era of new medicines.
Luyendijk M, Visser O, Blommestein HM, de Hingh IHJT, Hoebers FJP, Jager A, Sonke GS, de Vries EGE, Uyl-de Groot CA, Siesling S.
Luyendijk M, et al. Among authors: blommestein hm.
J Natl Cancer Inst. 2023 Jun 8;115(6):628-635. doi: 10.1093/jnci/djad020.
J Natl Cancer Inst. 2023.
PMID: 36978244
Free PMC article.